Lancet
-
Digoxin is a widely used drug for ventricular rate control in patients with atrial fibrillation (AF), despite a scarcity of randomised trial data. We studied the use and outcomes of digoxin in patients in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). ⋯ Janssen Research & Development and Bayer HealthCare AG.
-
Case Reports Historical Article
Hypoplastic left heart in the 6500-year-old Detmold Child.